首页 | 本学科首页   官方微博 | 高级检索  
检索        

氨磺必利治疗精神分裂症的疗效和安全性
引用本文:姜涛,迟勇,郑毅.氨磺必利治疗精神分裂症的疗效和安全性[J].神经疾病与精神卫生,2011,11(4):375-376.
作者姓名:姜涛  迟勇  郑毅
作者单位:1. 100088,首都医科大学附属北京安定医院四科八区
2. 100088,首都医科大学附属北京安定医院儿科
摘    要:目的 探讨氨磺必利治疗精神分裂症的疗效和安全性.方法 对45例成人精神分裂症患者进行为期12用的氨磺必利系统治疗,在治疗期间定期进行PANSS,TESS,CGI评定以及血常规、生化系列、心电图检查.结果 治疗前后PANSS,CGI评分均有显著性差异(P<0.000).最常见的不良反应是EPS和催乳素升高.结论 氨磺必利能有效治疗精神分裂症,无严重不良反应,安全性高.

关 键 词:精神分裂症  治疗结果  氨磺必利  安全性

Efficacy and Tolerability of amisulpride on schizophrenia
J IANG Tao,CHI Yong,ZHENG Yi.Efficacy and Tolerability of amisulpride on schizophrenia[J].Nervous Diseases and Mental Health,2011,11(4):375-376.
Authors:J IANG Tao  CHI Yong  ZHENG Yi
Institution:.( Beijing Anding Hospital, Capital Medical University, Beijing 100088 ,China )
Abstract:Objective To explore the efficacy and tolerability of amisulpride in schizophrenia. Methods 45 adults with schizophrenia received amisulpride treatment for 12 weeks. PANSS,CGI,TESS were used for assessement. Blood test, biochemistry and ECG were performed periodically. Results There were significant differences in PANSS and CGI comparing before and after the treatment in each group (P 〈 0. 000). The common side effects were EPS and insomnia. Conclusions Amisulpride had good efficacy and tolerability in the treatment of schizophrenia.
Keywords:Schizophrenia  Treatment outcome  Amisulpride  Tolerability
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号